Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP624142.RAnpB5G4I1sfpdGfJpPSzBmUJob8916W1rke5_Lcg4Oww130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP624142.RAnpB5G4I1sfpdGfJpPSzBmUJob8916W1rke5_Lcg4Oww130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP624142.RAnpB5G4I1sfpdGfJpPSzBmUJob8916W1rke5_Lcg4Oww130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP624142.RAnpB5G4I1sfpdGfJpPSzBmUJob8916W1rke5_Lcg4Oww130_provenance.
- NP624142.RAnpB5G4I1sfpdGfJpPSzBmUJob8916W1rke5_Lcg4Oww130_assertion description "[Here, we used low-density arrays, quantitative PCR, and western blotting to determine how HER2 signaling inhibition with lapatinib or PI3K inhibitors affects the expression of genes involved in breast cancer metastatic spread and overall prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624142.RAnpB5G4I1sfpdGfJpPSzBmUJob8916W1rke5_Lcg4Oww130_provenance.
- NP624142.RAnpB5G4I1sfpdGfJpPSzBmUJob8916W1rke5_Lcg4Oww130_assertion evidence source_evidence_literature NP624142.RAnpB5G4I1sfpdGfJpPSzBmUJob8916W1rke5_Lcg4Oww130_provenance.
- NP624142.RAnpB5G4I1sfpdGfJpPSzBmUJob8916W1rke5_Lcg4Oww130_assertion SIO_000772 20126311 NP624142.RAnpB5G4I1sfpdGfJpPSzBmUJob8916W1rke5_Lcg4Oww130_provenance.
- NP624142.RAnpB5G4I1sfpdGfJpPSzBmUJob8916W1rke5_Lcg4Oww130_assertion wasDerivedFrom befree-20150227 NP624142.RAnpB5G4I1sfpdGfJpPSzBmUJob8916W1rke5_Lcg4Oww130_provenance.
- NP624142.RAnpB5G4I1sfpdGfJpPSzBmUJob8916W1rke5_Lcg4Oww130_assertion wasGeneratedBy ECO_0000203 NP624142.RAnpB5G4I1sfpdGfJpPSzBmUJob8916W1rke5_Lcg4Oww130_provenance.
- befree-20150227 importedOn "2015-02-27" NP624142.RAnpB5G4I1sfpdGfJpPSzBmUJob8916W1rke5_Lcg4Oww130_provenance.